(Total Views: 96)
Posted On: 05/03/2021 11:50:47 AM
Post# of 36184

$SRPT News Article - Sarepta Therapeutics Reports Positive Clinical Results from Phase 2 MOMENTUM Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51 https://marketwirenews.com/news-releases/sare...51420.html


My Twitter: WhyteStocks